D
Teva Pharmaceutical Industries Limited TEVA
$15.38 -$0.07-0.45% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 282.00M 214.00M -217.00M -437.00M -846.00M
Total Depreciation and Amortization 251.00M 244.00M 269.00M 259.00M 259.00M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 30.00M 137.00M 768.00M 554.00M 700.00M
Change in Net Operating Assets -336.00M -700.00M -245.00M 317.00M -10.00M
Cash from Operations 227.00M -105.00M 575.00M 693.00M 103.00M
Capital Expenditure -96.00M -127.00M -129.00M -148.00M -97.00M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 0.00 -- --
Divestitures 9.00M 17.00M 4.00M 38.00M 1.00M
Other Investing Activities 323.00M 311.00M 327.00M 378.00M 274.00M
Cash from Investing 236.00M 201.00M 202.00M 268.00M 178.00M
Total Debt Issued 2.31B -- -- -- --
Total Debt Repaid -2.30B -1.37B -685.00M -- -956.00M
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 1.00M -376.00M 11.00M -- -10.00M
Cash from Financing 6.00M -1.74B -674.00M -- -966.00M
Foreign Exchange rate Adjustments -5.00M 45.00M -121.00M 100.00M -49.00M
Miscellaneous Cash Flow Adjustments -- -- -1.00M -- 1.00M
Net Change in Cash 464.00M -1.60B -19.00M 1.06B -733.00M